Three Low-Risk Stocks Poised for Growth This October
Oversold Stocks Opportunity: The consumer staples sector has several oversold stocks, presenting potential buying opportunities for undervalued companies, particularly those with an RSI below 30.
Tootsie Roll Industries: Tootsie Roll reported a third-quarter earnings increase but saw its stock drop 14% recently, with an RSI of 28.8 and a closing price of $36.05.
National Beverage Corp: National Beverage's quarterly sales were disappointing, leading to an 8% stock decline over the past month, an RSI of 21.4, and a closing price of $33.75.
Calavo Growers Inc: Calavo Growers faced weaker-than-expected quarterly results, resulting in a 10% stock drop, an RSI of 25.6, and a closing price of $23.21.
Trade with 70% Backtested Accuracy
Analyst Views on FIZZ
About FIZZ
About the author

- Healthcare Stocks Surge: Following the CMS proposal to increase payment rates by 2.4% for hospitals and ambulatory surgical centers, shares of Universal Health Services rose 7% and HCA Healthcare increased by 5%, reflecting market optimism towards the healthcare sector.
- Rivian's Delivery Outlook Raised: Rivian Automotive raised its 2026 delivery outlook from 62,000-67,000 to 65,000-70,000, resulting in an 8% stock price increase, indicating strong market confidence in its future growth potential.
- Blue Owl Capital Redemption Pressure Eases: Blue Owl Capital's stock jumped over 4% as a shareholder letter revealed that redemption requests for its private credit funds decreased to $4.7 billion in Q2 from $5.4 billion in Q1, suggesting improved market confidence in its liquidity.
- National Beverage's Special Cash Dividend: National Beverage Corp. announced a special cash dividend of $3.25 per share, leading to a 13% stock price increase, which not only enhances investor returns but may also attract more attention from potential investors.
- Cautious Market Sentiment: Ahead of America's Independence Day, stock futures are pointing lower as investors remain cautious due to the upcoming June jobs report and ongoing U.S.-Iran diplomatic talks, potentially leading to a softer end to the holiday-shortened week.
- National Beverage Gains: Shares of National Beverage (FIZZ) rose by 6% after announcing a special cash dividend of $3.25 per share, with FY2026 net sales reaching $1.2 billion, gross profit at $437 million with a 37% margin, and EPS of $1.96, reflecting strong innovation momentum and improving market conditions.
- Can-Fite BioPharma Decline: Can-Fite BioPharma (CANF) saw a 12% drop in shares despite reporting positive Phase 2a data for Namodenoson in advanced pancreatic cancer, indicating market skepticism about the drug's future clinical trials despite meeting safety endpoints and showing durable survival rates.
- Embraer Acquisition Impact: Embraer (EMBJ) shares fell by 5% after completing the acquisition of Safran Cabin's remaining 50% stake in the EZ Air Interior joint venture, raising concerns about the financial implications and integration of operations despite gaining full ownership of the cabin interiors production facility.
- Earnings Highlights: National Beverage reported a FY GAAP EPS of $1.96, with revenue of $1.18 billion reflecting a 1.7% year-over-year decline, indicating pressure and challenges in a competitive market landscape.
- Special Dividend Announcement: The board declared a special cash dividend of $3.25 per share for shareholders of record on July 13, 2026, to be paid on or before July 30, 2026, aimed at enhancing shareholder returns and boosting investor confidence.
- Market Position Analysis: Among mid-cap consumer staples, National Beverage ranks as one of the least attractively valued stocks, reflecting market caution regarding its future growth potential, which may impact its stock performance.
- Internal Governance Risks: The company faces internal control and governance risks, particularly with a high executive ownership stake, which may lead to misalignment of interests and affect the transparency and effectiveness of corporate decision-making.
- Earnings Performance: National Beverage reported a Q3 GAAP EPS of $0.44, aligning with market expectations, indicating stability in the company's profitability.
- Revenue Decline: The company’s revenue for Q3 was $264.59 million, reflecting a year-over-year decrease of 0.9%, missing market expectations by $5.13 million, highlighting challenges from increased market competition and changing consumer demand.
- Market Reaction Analysis: Although the EPS met expectations, the revenue miss may create pressure on the stock price in the future, as ongoing revenue declines could impact investor confidence.
- Future Outlook: The company needs to closely monitor market dynamics and implement effective strategies to address the revenue decline trend, ensuring sustained growth and profitability in the competitive beverage market.

- Stable Sales Performance: National Beverage Corp. reported net sales of $265 million for Q3, choosing not to pass the full tariff costs to consumers, thereby maintaining its competitive edge in the market.
- Significant Profit Growth: The company achieved a gross profit of $100 million, reflecting a 60 basis point year-over-year margin improvement, demonstrating successful strategies in balancing product pricing and margins, which further boosts investor confidence.
- Popular Innovative Products: The newly launched ‘harmoniously combined’ PineApple CocoNut beverage received an overwhelmingly favorable response at the Natural Products Expo West, indicating the company's strategic direction in meeting consumer demand for multisensory experiences.
- Strong Cash Flow: Operating cash flow reached $136 million, with quarter-end cash growing to $314 million, reflecting the company's ongoing investment capability in healthy innovative products and laying a solid foundation for future growth.
National Beverage Corp. Price Adjustment: National Beverage Corp. has reduced its target price from $35 to $34.
Market Impact: This price cut may reflect changes in market conditions or company performance expectations.





